Efeito de uma intervenção de reabilitação psicomotora em pessoas idosas institucionalizadas ao nível de indicadores de saúde e do bem-estar

Objetivo: Investigar os benefícios de um programa de reabilitação psicomotora em pessoas idosas institucionalizadas ao nível de indicadores de saúde e do bem-estar. Metodologia: A amostra integrou 42 participantes (84±6.2 anos), dos quais 21 pertenciam ao grupo experimental (programa de reabilitação) e 21 ao grupo controlo. Os indicadores de saúde e bem-estar foram avaliados pelo Profile of Mood Stats (POMS), pela Escala de Dor (Instrumento P4), pela Perceção de Estado de Saúde (EQVAS) e pelo Índice de Barthel. Resultados: Os testes de comparação evidenciaram melhorias significativas no grupo experimental, nas variáveis depressão, irritação, confusão, principalmente no score total sem e com irritação da avaliação de estados emocionais e de humor, em relação à escala de dor as variáveis escala de dor1 e score total escala de dor foram as que tiveram melhorias significativas, p= <0.05. Conclusão: O programa de reabilitação psicomotora promoveu melhorias ao nível dos indicadores de saúde e do bem-estar das pessoas idosas institucionalizadas, com maior impacto nos estados emocionais e de humor e diminuição de intensidade de dor; Abstract: Effect of a psychomotor rehabilitation intervention in elderly people institutionalized at the level of health indicators and welfare. Objective: The aim is to investigate the benefits of a psychomotor rehabilitation program in orderly people institutionalized at the level of health indicators and welfare. Methodology: The sample consisted of 42 participants (84 ± 6.2 years), 21 of them belonged to the experimental group (rehabilitation program), and the other 21, to the control group. The following surveys were conducted by the Profile of Mood Stats (POMS), the Pain Scale (P4 Instrument), the Perception of Health Status (EQVAS) and the Barthel Index. Results: Significant improvements were observed in the experimental group, in the following dimensions: depression, anger, confusion, mainly in the total score with and without irritation assessment of emotional states and mood, regarding the pain scale, the variables pain scale and total average score were the ones that had higher significant improvements, p = <0.05. Conclusion: The psychomotor rehabilitation program led to improvements in health indicators and well-being of the institutionalized older ones, with greater impact on emotional states and mood and decrease in pain intensity.

A low fermentable oligo-di-mono saccharides and polyols (FODMAP) diet reduced pain and improved daily life in fibromyalgia patients

Fibromyalgia (FM) is a chronic, rheumatic disease characterized by widespread myofascial pain, of unknown aetiology, having a major impact on quality of life (QOL). Available pharmacotherapy for FM is marginally effective. FM is associated with co-morbidities of gastrointestinal (GI) disorders and Irritable Bowel Syndrome (IBS). There is growing evidence that diets low in FODMAPs, “fermentable oligo-, di- or mono-saccharides and polyols” [Low FODMAP Diet (LFD)], are effective in treating IBS. The aim of this pilot study was to examine the effects of LFDs on symptoms of FM, especially with regard to pain, QOL and GI disorders. Methods A longitudinal study using LFD intervention was performed on 38, 51 ± 10 year-old, female patients diagnosed with FM for an average of 10 years, based on ACR (American College of Rheumatology) 2010 criteria. The study was conducted from January through May, 2015, using a four-week, repeated-assessment model, as follows: Moment 0 – introduction of the protocol to participants; Moment 1 – first assessment and delivery of individual LFD dietary plans; Moment 2 – second assessment and reintroduction of FODMAPs; Moment 3 – last assessment and final nutritional counselling. Assessment tools used were the following: RFIQ (Revised Fibromyalgia Impact Questionnaire), FSQ (Fibromyalgia Survey Questionnaire), IBS-SSS (Severity Score System), EQ-5D (Euro-QOL quality of life instrument), and VAS (Visual Analogue Scale). Daily consumption of FODMAPs was quantified based on published food content analyses. Statistical analyses included ANOVA, non-parametric Friedman, t-student and Chi-square tests, using SPSS 22 software. Results The mean scores of the 38 participants at the beginning of the study were: FSQ (severity of FM, 0–31) – 22 ± 4.4; RFIQ (0–100) – 65 ± 17; IBS-SSS (0–500) – 275 ± 101; and EQ-5D (0–100) – 48 ± 19. Mean adherence to dietary regimens was 86%, confirmed by significant difference in FODMAP intakes (25 g/day vs. 2.5 g/day; p < 0.01). Comparisons between the three moments of assessment showed significant (p < 0.01) declines in scores in VAS, FSQ, and RFIQ scores, in all domains measured. An important improvement was observed with a reduction in the severity of GI symptoms, with 50% reduction in IBS scores to 138 ± 117, following LFD therapy. A significant correlation (r = 0.36; p < 0.05) was found between improvements in FM impact (declined scores) and gastrointestinal scores. There was also a significant correlation (r = 0.65; p < 0.01) between “satisfaction with improvement” after introduction of LFDs and “diet adherence”, with satisfaction of the diet achieving 77% among participants. A significant difference was observed between patients who improved as compared to those that did not improve (Chi-square χ2 = 6.16; p < .05), showing that the probability of improvement, depends on the severity of the RFIQ score. Conclusions Implementation of diet therapy involving FODMAP restrictions, in this cohort of FM patients, resulted in a significant reduction in GI disorders and FM symptoms, including pain scores. These results need to be extended in future larger studies on dietary therapy for treatment of FM. Implications According to current scientific knowledge, these are the first relevant results found in an intervention with LFD therapy in FM and must be reproduced looking for a future dietetic approach in FM.